Cancer News and Research

Latest Cancer News and Research

Hospitals treating more black cancer patients experience worse survival rates

Hospitals that treat more black cancer patients have worse survival rates on average for patients with breast and colon cancer, regardless of race, according to a new study from the University of Michigan Comprehensive Cancer Center.

21 Aug 2009

More evidence that genes increase a smokers' risk of lung cancer

Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.

21 Aug 2009

Research reveals smokeless tobacco users at higher risk of a heart attack or stroke

People who use smokeless tobacco products like snus have a slightly higher risk of having a fatal heart attack or stroke, according to research published on bmj.com today.

21 Aug 2009

Adena Health System implements Medseek's eHealth ecoSystem to improve health care workflow for physicians

MEDSEEK, the leading provider of healthcare enterprise portal connectivity solutions, announced today that Adena Health System is expanding the capabilities of its existing MEDSEEK-powered eHealth ecoSystem to include additional services that will allow it to remain competitive in a rapidly changing healthcare market. The additional eHealth functionality will meet the increasing demands of today’s consumers, further enhance patient satisfaction and solve complex patient referral problems for its community physicians, ultimately improving the delivery and reducing the cost of care.

21 Aug 2009

Alliance with GE Healthcare enables Moffitt Cancer Center optimize patient care capacity

More than half of U.S. hospitals are capacity constrained and unable to add patients without facility expansion or extended hours. GE Healthcare and Moffitt Cancer Center announced an alliance aimed to optimize efficiency and care capacity, and in less than eight months Moffitt has added capacity for 900 new cancer procedures and additional operating margin.

21 Aug 2009

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein-a cancer vaccine-that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.

21 Aug 2009

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL Diagnostics Inc. (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-Sure(TM)-- AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.

21 Aug 2009

Coping with burn injuries

More than half a million Americans are treated for burn injuries every year, but many do not have the specific skills necessary to cope with the experience of living with a burn injury after they leave the hospital.

20 Aug 2009

Kennedy pushes fast transition as hopes dim for his return to Washington

Sen. Edward Kennedy, D-Mass., "is trying to make sure that the leading cause in his life, better health coverage for all, advances in the event of his death" with a recent letter to Massachusetts Gov. Deval Patrick and leaders in the state legislature, the Boston Globe reports.

20 Aug 2009

Rex Healthcare Laboratory to provide billing, marketing and business support services to Pathology Service Associates

Pathology Service Associates, LLC (PSA), a MED3OOO Company, was recently selected by Rex Healthcare Laboratory for revenue cycle management (billing), marketing, and business support services.

20 Aug 2009

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

...

20 Aug 2009

Advaxis awarded $210,000 for development of a dual antigen vaccine

Advaxis, Incorporated (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, has been awarded a $210,000 grant from the US National Institute of Health (NIH) to develop a single bioengineered Lm vaccine to deliver two different antigen-adjuvant proteins.

20 Aug 2009

Varian Medical Systems to equip a new proton therapy center in Sweden

Varian Medical Systems today announced it has been selected to equip a new proton therapy center in Sweden. In a ceremony conducted by Swedish authorities yesterday following a public tender, Varian was named to supply an estimated $60 million in products for Skandionkliniken, a new national proton therapy center owned by a consortium of seven of Sweden's counties.

20 Aug 2009

Seasonal flu vaccinations to cost less in Safeway's U.S. Stores

Safeway Inc. (NYSE:SWY) added to its leadership reputation in health care reform and cost control by offering seasonal flu vaccines in its U.S. stores at a substantial savings compared with the cost of doctor-administered vaccines. The lower cost will help consumers and businesses control health care spending in a challenging economy.

20 Aug 2009

Helicos Genetic Analysis System to aid Ontario Institute for Cancer Research scientists in the study of cancer genomics

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Ontario Institute for Cancer Research (OICR) with Drs. Tom Hudson and John McPherson.

20 Aug 2009

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Hologic, Inc. has announced the publication of the first of its kind study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic and asymptomatic pregnant women at risk for preterm birth. The study, "Does fetal fibronectin testing change patient management in women at risk of preterm labour?" by researchers at King's College, London, England appears in the on-line version of the European Journal of Obstetrics & Gynecology and Reproductive Biology.

20 Aug 2009

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today it has been granted U.S. patent 7,566,567 by the United States of America Patent and Trademark Office covering its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines.

20 Aug 2009

Zila starts proxy vote on proposed merger with TOLMAR Holding

Zila, Inc. announced that Proxy Statements and Proxies have been mailed to its stockholders in order to allow them to vote on the proposed merger with a subsidiary of TOLMAR Holding, Inc. Under the terms of the merger agreement, if approved by the stockholders, each Zila stockholder would be entitled to receive $0.45 per share in cash. Tolmar is a privately held, pharmaceutical research, development, manufacturing and commercial operations company.

20 Aug 2009

The Dilemma of an Aging Society research study classifies elder people into four groups

A lot of discussion has centered on proposed legislation regarding "death panels" and end of life counseling.

20 Aug 2009

Novel microRNA plays a major role in invasive breast cancer development

Research led by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, has shown for the first time that a tiny piece of RNA appears to play a major role in the development of invasive breast cancer and identified a gene that appears to inhibit invasive breast cancer.

20 Aug 2009

Cancer News and Research

Latest Cancer News and Research

Hospitals treating more black cancer patients experience worse survival rates

More evidence that genes increase a smokers' risk of lung cancer

Research reveals smokeless tobacco users at higher risk of a heart attack or stroke

Adena Health System implements Medseek's eHealth ecoSystem to improve health care workflow for physicians

Alliance with GE Healthcare enables Moffitt Cancer Center optimize patient care capacity

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

Coping with burn injuries

Kennedy pushes fast transition as hopes dim for his return to Washington

Rex Healthcare Laboratory to provide billing, marketing and business support services to Pathology Service Associates

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

Advaxis awarded $210,000 for development of a dual antigen vaccine

Varian Medical Systems to equip a new proton therapy center in Sweden

Seasonal flu vaccinations to cost less in Safeway's U.S. Stores

Helicos Genetic Analysis System to aid Ontario Institute for Cancer Research scientists in the study of cancer genomics

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

Zila starts proxy vote on proposed merger with TOLMAR Holding

The Dilemma of an Aging Society research study classifies elder people into four groups

Novel microRNA plays a major role in invasive breast cancer development

Understanding the DNA Damage Response in Innate Immunity eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in